Spire Wealth Management Cidara Therapeutics, Inc. Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$0.64 - $0.92 $3,218 - $4,626	5,029 Added 101.17%	10,000 $9,000
Q4 2023 Feb 06, 2024	SELL	$0.68 - $0.97 $27 - $39	-41 Reduced 0.82%	4,971 $3,000
Q3 2023 Nov 08, 2023	BUY	$0.77 - $1.16 $9 - $13	12 Added 0.24%	5,012 $4,000
Q2 2023 Aug 09, 2023	BUY	$1.01 - $1.42 $1,010 - $1,420	1,000 Added 25.0%	5,000 $5,000
Q1 2023 May 09, 2023	BUY	$0.75 - $1.98 $3,000 - $7,920	4,000 New	4,000 $5,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.